A significant discovery in cancer investigation is arising with the use of nanobodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently lost in several kinds of malignancies, leading https://mypresspage.com/story7064626/vhh-fragments-reactivate-p53-a-potential-pathway-for-tumor-therapy